Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus capsules for severe myasthenia gravis with insufficient steroid response
CTR20132669Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in myasthenia gravis (MG), sponsored by Astellas Pharma. Started Mar 2014; status: completed.
02
Drugs
tacrolimus
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on CTR20132669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132669.